Huddersfield Fully Funded PhD, VLP Drug Delivery – Apply by 6 Jan
This Huddersfield funded PhD notification is for a Fully Funded 4-Year PhD Studentship at the University of Huddersfield focusing on a Modular Adhiron-VLP Platform for Targeted Molecular Delivery, with an application deadline of 6 January 2027.
Job Details
Position: Fully Funded 4-Year PhD Studentship
Location: University of Huddersfield, UK
Funding: Fully funded for 4 years – tax-free UKRI-rate stipend, research costs and tuition fees at the UK rate. A very limited number of international bursaries provide full studentships for international (EU and non-EU) applicants at Huddersfield; these are highly competitive. International students must cover visa, NHS health surcharge, travel insurance and travel costs.
Application Deadline: 6 January 2027 (5pm UK time)
Huddersfield Funded PhD: Project Details
A central challenge in targeted delivery is the lack of a truly modular platform in which the targeting molecule, the display scaffold and the payload can each be varied independently. Antibody-drug conjugates often suffer from poor solid-tumour penetration, immunogenicity and off-target uptake, and their fixed chemistries rarely generalise across payloads and disease targets. This PhD will develop a modular virus-like particle (VLP) display platform functionalised with adhirons – compact, highly thermostable synthetic binding proteins with antibody-like affinity – with cancer-targeted delivery as the first application. Building on earlier work using Cowpea Mosaic Virus (CPMV) VLPs targeted to HER2-positive tumours, the student will turn this proof-of-concept into a plug-and-play delivery system. This Huddersfield funded PhD will develop the platform beyond its initial proof of concept.
Key Responsibilities
- Isolate new adhirons against additional cancer targets and engineer VLPs to display them, showing the platform is not fixed to one target.
- Develop site-specific enzymatic conjugation (sortases and arginyl endopeptidases) to couple VLPs with diverse payloads, including chemotherapeutics and oncolytic protein payloads.
- Validate constructs for receptor binding, internalisation and cytotoxicity in vitro, then test targeting, stability and toxicity using human tumour xenografts in the chorioallantoic membrane (CAM) in ovo model – a 3Rs-aligned alternative ahead of mammalian work.
Eligibility Criteria
- Applicants with, or expecting, at least an upper second-class honours degree (or equivalent) in any biological, chemical or physical science or mathematics.
- Open to UK (home) and international applicants; state whether you are applying as a home or international student.
- International applicants must meet the University of Huddersfield’s entry and English language requirements.
How to Apply
Submit the BBSRC Yorkshire Bioscience DTP 2027 expression of interest via the ‘Apply Now’ page of the DTP website (yorkshirebiosciencedtp.ac.uk), selecting this project. You may apply to up to two YBDTP projects. Discussing your background with Dr McCaul before applying is recommended. Not all projects will be funded; studentships are awarded competitively.
CLICK HERE FOR THE ORIGINAL NOTIFICATION / APPLY ONLINE
The application deadline for this Huddersfield funded PhD is 6 January 2027.
Questions and comments